Evolus launches Nuceiva toxin in Italy
Pharmaceutical company Evolus has expanded to offer the neurotoxin Nuceiva in Italy.
Pharmaceutical company Evolus has expanded to offer the neurotoxin Nuceiva in Italy.
Pharmaceutical company Evolus has expanded its UK distribution, with its toxin Nuceiva now being sold through Healthxchange and Medfx as well as Wigmore Medical.
Aesthetic pharmaceutical company Evolus has announced it is to be the exclusive US distributor of five dermal fillers, currently in late-stage development.
Medical aesthetic company Evolus has announced a series of regional roadshow dates across the UK, allowing medical professionals to learn more about Evolus and its toxin Nuceiva.
Medical aesthetic company Evolus has announced that its neurotoxin Nuceiva has received approval for sale in Australia.
Medical aesthetic company Evolus has appointed two new staff members to its team.
Medical aesthetic company Evolus Inc has announced that the European Commission (EC) has approved the marketing of Nuceiva prabotulinumtoxinA (branded Jeuveau in the US and known in other markets as Nabota).
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on the marketing authorisation application for Evolus’ botulinum toxin type A formulation.
The Food and Drug Administration (FDA) has approved Jeuveau, a botulinum toxin type A, for the temporary improvement in the appearance of moderate to severe glabellar lines.
We bring you the most up-to-date information for the Aesthetics community across a variety of media, including; news, webinars, podcasts, the Journal, reports, interviews and more!
aesthetics Journal
The Aesthetics Journal is the leading monthly publication for the medical aesthetics specialty. It is peer reviewed and spans an incredible volume of topics. Become a member today to receive the monthly print and digital Journal.
0203 096 1228
2nd Floor, Regal House, 70 London Road
Twickenham TW1 3QS, United Kingdom
© 2023 Easyfairs UK Ltd | Registered in England No. 05067979